Targeting Signaling Pathways in Solid Tumors Part B
- 1st Edition, Volume 386 - May 23, 2024
- Latest edition
- Editors: Sumit Mukherjee, Kaushiki Chatterjee
- Language: English
Targetting Signaling Pathways in Solid tumour Part B, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an int… Read more
Targetting Signaling Pathways in Solid tumour Part B, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.
- Provides the latest information on cancer research
- Offers outstanding and original reviews on a range of cancer research topics
- Serves as an indispensable reference for researchers and students alike
Researchers, Medical Professionals, Students
1. Cellular Signaling in Glioblastoma- a Molecular and Clinical perspective
Debarati Ghosh
2. Therapeutic potential of hedgehog signaling in advanced cancer types
Richa Singh and Anindita Ray
3. When 'infected', do not just 'stress' out, also 'recycle'! : the paramount importance of ER stress and autophagy in oncovirus-mediated solid tumors
SOUNAK Ghosh Roy, ANIRBAN GANGULY and Shovan Dutta
4. The crosstalk between miRNAs and signalling pathways in human cancers: potential therapeutic implications
Ritu Shekhar
5. Targeting KRAS and SHP2 signaling pathways for immunomodulation and improving treatment outcome in solid tumors
Dr Anirban Ganguly
6. Role of Mitochondria driven innate inflammatory pathways in cancer progression
Sanjay Pandey and Vandana Anang
Debarati Ghosh
2. Therapeutic potential of hedgehog signaling in advanced cancer types
Richa Singh and Anindita Ray
3. When 'infected', do not just 'stress' out, also 'recycle'! : the paramount importance of ER stress and autophagy in oncovirus-mediated solid tumors
SOUNAK Ghosh Roy, ANIRBAN GANGULY and Shovan Dutta
4. The crosstalk between miRNAs and signalling pathways in human cancers: potential therapeutic implications
Ritu Shekhar
5. Targeting KRAS and SHP2 signaling pathways for immunomodulation and improving treatment outcome in solid tumors
Dr Anirban Ganguly
6. Role of Mitochondria driven innate inflammatory pathways in cancer progression
Sanjay Pandey and Vandana Anang
- Edition: 1
- Latest edition
- Volume: 386
- Published: May 23, 2024
- Language: English
SM
Sumit Mukherjee
I am a dynamic scientist with broad knowledge and research experience in cancer biology and cancer immunology. I am a highly skilled researcher with exceptional leadership and team-building capabilities. I have 10+ years of cancer research experience in academia as PhD student and Postdoctoral researcher. I have a track record of presenting and publishing scientific data in a timely and organized fashion as attested by my publication record of 12 published research articles with 6 as first-author. I am also a subject matter expert in preclinical cancer immunology as evidenced by my authored review articles with being co-corresponding author for one such review article. I have frequently peer-reviewed multiple articles for publication as peer-reviewer and guest editor. My Postdoctoral work focused on a novel immunosuppressive/protumor cancer cell expressing enzyme ART1’s discovery and further developing it as a therapeutic target in lung cancers and melanoma tumors utilizing murine in vivo models and patient samples. My doctoral research specialized in natural product-mediated (like curcumin) therapeutic intervention of cancers by modulating cancer cell signaling and cancer micro-environment immune system. My doctoral research also involved studying the mechanistic underpinning of cancer cell signaling & tumor microenvironment immunology for therapeutic targeting of brain tumors and cervical cancer models.
Affiliations and expertise
Cardiothoracic and Vascular Surgery,Albert Einstein College of Medicine BronxKC
Kaushiki Chatterjee
As a skilled scientist with expertise in cancer biology, stem cell biology, and epigenetics, I am deeply passionate about advancing scientific knowledge. In my current postdoctoral role, I investigate the role of disease-relevant histone modifiers in shaping the epigenetic landscape of stem cells. My active involvement in multiple projects demonstrates my commitment to collaboration and leveraging collective knowledge to achieve impactful results. I have a track record of mentoring students and actively encouraging diversity in STEM, especially among women pursuing research careers. In my doctoral research, I contributed to understanding the anti-tumor potential of plant polyphenols in cervical cancer. I have published several research and review articles in cancer biology and stem cell epigenetics Through my multifaceted contributions over the course of over 10 years, I aim to inspire the next generation of scientists while leaving a lasting impact on scientific endeavors.
Edit
Affiliations and expertise
Medicine Weill Cornell Medicine, New YorkRead Targeting Signaling Pathways in Solid Tumors Part B on ScienceDirect